Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
CONCLUSION: In clinical practice, the use of PIVKA-II + AFP in addition to US examination may improve the effectiveness of surveillance among patients at risk for HCC development.
PMID: 29667463 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemistry | Cirrhosis | Databases & Libraries | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | PET Scan | Study | Urology & Nephrology | Vitamin K | Vitamins